As Director of Research in the Department of Cardiology, Prof Hare supervises a number of research groups, a major one being a “Psychosocial” research group, others including a “wet “ vascular laboratory, a clinical cardio-vascular laboratory, an exercise research group and a clinical trials group primarily working in heart failure.
Measuring Adverse Events: Development Of A Patient-Centred Adverse Event Reporting Tool (PAET)
Funder
National Health and Medical Research Council
Funding Amount
$454,721.00
Summary
The decision to treat a patient depends on knowing whether the treatment does more good than harm. If it is likely that the treatment will work as well as or better than other treatments and will have minimal associated risks, then that treatment would be recommended unless unavailable or prohibited by cost. Given two equally effective treatments the one with fewer side effects and greater tolerability would be preferred by all. In the process of acquiring knowledge on treatment benefit and trea ....The decision to treat a patient depends on knowing whether the treatment does more good than harm. If it is likely that the treatment will work as well as or better than other treatments and will have minimal associated risks, then that treatment would be recommended unless unavailable or prohibited by cost. Given two equally effective treatments the one with fewer side effects and greater tolerability would be preferred by all. In the process of acquiring knowledge on treatment benefit and treatment harm we rely on evidence from clinical trials. However, the evaluation of benefit versus harm is not symmetric in this setting. Much more effort (e.g. study design, study power, standardisation of efficacy outcome measures) goes into the assessment of whether a treatment works and rather than its potential harm, as measured by adverse events. Adverse event ascertainment and reporting is poorly standardised . There is no standardised measurement process that elicits adverse event information. There is no standardised method for quantifying adverse event information into an index or profile scores equivalent to instruments developed to measure health status, quality of life and other benefits of treatment. Developing astandardised Patient-centred Adverse Event Questionnaire will benefit multiple stakeholders. For Patients: An easy to understand summary measure of treatment harm aids patient understanding of the benefit versus risk. For Doctors, allied health professionals: The Questionnaire includes drug profiles, to align a drug profile with an individual patient's clinical profile. This leads to better patient care. In health policy: All of the above has flow-on effects for policy. Better adverse event data will facilitate information and understanding generally of risks of treatments, risk-benefits of treatments, and cost-effectiveness of management strategies.Read moreRead less
Improving Quality Of Life In High-risk Cancer Populations: A Randomised Trial Of A Structured Intervention For Head And Neck Cancer Survivors
Funder
National Health and Medical Research Council
Funding Amount
$493,220.00
Summary
Patients treated for head and neck cancer commonly experience pain, disfigurement, eating difficulties, depression and fatigue, undermining confidence and quality of life. This study aims to help patients self-manage their ongoing health problems following completion of treatment. This will be achieved through a randomised trial in which patients will be assisted by a trained oncology nurse to develop a tailored survivorship care plan focusing on the patient’s specific medical and emotional conc ....Patients treated for head and neck cancer commonly experience pain, disfigurement, eating difficulties, depression and fatigue, undermining confidence and quality of life. This study aims to help patients self-manage their ongoing health problems following completion of treatment. This will be achieved through a randomised trial in which patients will be assisted by a trained oncology nurse to develop a tailored survivorship care plan focusing on the patient’s specific medical and emotional concerns.Read moreRead less
Nanoparticles with structures that mimic enzymes for electrocatalysis. This project aims to create a new class of electrocatalysts with architectures inspired by enzymes. Electrocatalysts are the backbone of the modern energy economy. In the new electrocatalysts developed by the project, the intention is the active sites will be spatially separated from the bulk solution by nanopores, as enzymes do. This architecture allows the reaction environment to be altered from the bulk solution, active tr ....Nanoparticles with structures that mimic enzymes for electrocatalysis. This project aims to create a new class of electrocatalysts with architectures inspired by enzymes. Electrocatalysts are the backbone of the modern energy economy. In the new electrocatalysts developed by the project, the intention is the active sites will be spatially separated from the bulk solution by nanopores, as enzymes do. This architecture allows the reaction environment to be altered from the bulk solution, active transport of species to the active site and cascade reactions to be performed. This should give advantages in activity, selectivity and the ability to perform multistep reactions. The intended outcomes are better performing hydrogen fuel cells and more effective conversion of carbon dioxide into useful organic compounds.Read moreRead less
Discovery Early Career Researcher Award - Grant ID: DE230101346
Funder
Australian Research Council
Funding Amount
$418,893.00
Summary
Cave microbial metabolism as a missing biogeochemical sink. The aim of this project is to unveil the microbial biodiversity, novel metabolic capabilities and chemosynthetic primary production of subsurface ecosystems, such as those found in caves. Leveraging a powerful blend of geospatial, molecular and biogeochemical approaches this project expects to identify the microbial basis of subsurface biogeochemical processes driving the earth’s major elementary cycles. Expected outcomes include a pred ....Cave microbial metabolism as a missing biogeochemical sink. The aim of this project is to unveil the microbial biodiversity, novel metabolic capabilities and chemosynthetic primary production of subsurface ecosystems, such as those found in caves. Leveraging a powerful blend of geospatial, molecular and biogeochemical approaches this project expects to identify the microbial basis of subsurface biogeochemical processes driving the earth’s major elementary cycles. Expected outcomes include a predictive framework to assess and upscale the impact of these microbial communities on the environment. Benefits include predicting and responding to climate risks, such as the desertification of agricultural soils, by uncovering how microorganisms respond to nutrient and carbon depletion.Read moreRead less